Vinik Aaron I, Chaya Celine
Division of Endocrinology and Metabolism, Department of Medicine, Strelitz Diabetes and Neuroendocrine Center, Eastern Virginia Medical School, 855 West Brambleton Avenue, Norfolk, VA 23510, USA.
Division of Endocrinology and Metabolism, Department of Medicine, Strelitz Diabetes and Neuroendocrine Center, Eastern Virginia Medical School, 855 West Brambleton Avenue, Norfolk, VA 23510, USA.
Hematol Oncol Clin North Am. 2016 Feb;30(1):21-48. doi: 10.1016/j.hoc.2015.08.006. Epub 2015 Oct 24.
Neuroendocrine tumors (NETs) are slow-growing neoplasms capable of storing and secreting different peptides and neuroamines. Some of these substances cause specific symptom complexes, whereas others are silent. They usually have episodic expression, and the diagnosis is often made at a late stage. Although considered rare, the incidence of NETs is increasing. For these reasons, a high index of suspicion is needed. In this article, the different clinical syndromes and the pathophysiology of each tumor as well as the new and emerging biochemical markers and imaging techniques that should be used to facilitate an early diagnosis, follow-up, and prognosis are reviewed.
神经内分泌肿瘤(NETs)是一种生长缓慢的肿瘤,能够储存和分泌不同的肽类和神经胺。其中一些物质会引发特定的症状群,而其他物质则无明显症状。它们通常呈间歇性表达,诊断往往在晚期才得以做出。尽管被认为较为罕见,但NETs的发病率正在上升。基于这些原因,需要高度的怀疑指数。在本文中,将对不同的临床综合征、每种肿瘤的病理生理学以及用于促进早期诊断、随访和预后评估的新出现的生化标志物和成像技术进行综述。